ET
SNDX icon

Entropy Technologies’s Syndax Pharmaceuticals SNDX Stock Holding History

Entropy Technologies’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Buy
+26,453
New +$550K 0.02% 634
2026
Q1 		– Sell
-15,064
Closed -$316K – 1143
2025
Q4 		$316K Buy
+15,064
New +$263K 0.02% 692
2024
Q2 		– Sell
-16,590
Closed -$395K – 913
2024
Q1 		$395K Sell
16,590
-13,981
-46% -$312K 0.04% 501
2023
Q4 		$661K Buy
+30,571
New +$470K 0.12% 280

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Entropy Technologies's SNDX Position: Q2 2026 in Review

Entropy Technologies opened a new position in Syndax Pharmaceuticals (SNDX) in Q2 2026: 26,453 shares worth $578K. The stake represents 0.02% of the portfolio and ranks #634 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in SNDX as recently as Q4 2025.

Entropy Technologies first reported a position in SNDX in Q4 2023 and has held it in 4 quarters since. The position peaked at $661K in Q4 2023. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Entropy Technologies held 26,453 shares of Syndax Pharmaceuticals worth $578K as of Q2 2026.
  • Syndax Pharmaceuticals was a new Entropy Technologies position in Q2 2026.
  • Syndax Pharmaceuticals made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #634 holding.
  • Entropy Technologies first reported a position in Syndax Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Entropy Technologies's Syndax Pharmaceuticals position peaked at $661K in Q4 2023.
  • 242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.